Dr. Margolin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Department of Medical Oncology
City of Hope
Duarte, CA 91010Phone+1 800-826-4673Fax+1 626-218-8233- Is this information wrong?
Education & Training
City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1985- City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1984
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
Stanford University School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1982 - 2025
WA State Medical License 2008 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma Start of enrollment: 2006 Nov 01
- Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma Start of enrollment: 2019 Nov 27
Publications & Presentations
PubMed
- The Dance Between Tumor Molecular Biology and Antitumor Immune Response.Kim A Margolin> ;Clinical Cancer Research. 2024 Jan 17
- 1 citationsMulti-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.Gino K In, Jennifer R Ribeiro, Jun Yin, Joanne Xiu, Matias A Bustos, Fumito Ito, Frances Chow, Gabriel Zada, Lindsay Hwang, April K S Salama, Soo J Park, Justin C Mose...> ;NPJ Precision Oncology. 2023 Nov 14
- 3 citationsNational Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.Michelle M Kim, Minesh P Mehta, DeeDee K Smart, Patricia S Steeg, Julie A Hong, Michael G Espey, Pataje G Prasanna, Laura Crandon, Christine Hodgdon, Niki Kozak, Terri...> ;The Lancet. Oncology. 2023 Aug 1
- Join now to see all
Journal Articles
- Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaIgor Puzanov, Kim A Margolin, Jose Lutzky, Ahmad Tarhini, Nageatte Ibrahim, JAMA Oncology
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainKim Margolin, Omid Hamid, Christopher D Lao, Anna C Pavlick, Michael A Postow, F Stephen Hodi, Nikhil I Khushalani, Marc S Ernstoff, Hussein A Tawbi, Igor Puzanov, Ahm..., The New England Journal of Medicine
Authored Content
- Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020
- Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced MelanomaJuly 2020
Press Mentions
What Is the Latest Research on the Form of Cancer Jimmy Carter Has?March 3rd, 2023- Immunotherapy: Researchers Identify Ways to Help Predict Outcomes for Cancer TreatmentFebruary 14th, 2023
- Oncologist Joins Saint John’s Cancer InstituteSeptember 1st, 2021
- Join now to see all
Grant Support
- Academic Industry AwardMelanoma Research Alliance, Altor Bioscience2012–2014
Other Languages
- Spanish, French, Portuguese
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Providence Saint John's Health CenterSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
